Alethea Capital Management LLC Boosts Position in RA Medical Systems Inc (RMED)

Alethea Capital Management LLC increased its holdings in shares of RA Medical Systems Inc (NYSE:RMED) by 134.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 206,980 shares of the company’s stock after acquiring an additional 118,523 shares during the period. RA Medical Systems makes up 0.5% of Alethea Capital Management LLC’s investment portfolio, making the stock its 28th largest holding. Alethea Capital Management LLC owned about 1.61% of RA Medical Systems worth $704,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. BlackRock Inc. purchased a new position in RA Medical Systems in the fourth quarter worth about $98,000. Sit Investment Associates Inc. raised its holdings in RA Medical Systems by 161.4% in the fourth quarter. Sit Investment Associates Inc. now owns 27,450 shares of the company’s stock worth $218,000 after buying an additional 16,950 shares during the last quarter. Marshall Wace North America L.P. purchased a new position in RA Medical Systems in the third quarter worth about $268,000. FNY Investment Advisers LLC purchased a new position in RA Medical Systems in the fourth quarter worth about $287,000. Finally, Kornitzer Capital Management Inc. KS raised its holdings in RA Medical Systems by 208.4% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 77,100 shares of the company’s stock worth $613,000 after buying an additional 52,100 shares during the last quarter. 31.00% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Dean Irwin sold 21,982 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $3.82, for a total transaction of $83,971.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Several research firms have recently weighed in on RMED. Zacks Investment Research cut shares of RA Medical Systems from a “hold” rating to a “sell” rating in a report on Saturday, April 20th. SunTrust Banks reissued a “positive” rating and set a $10.00 price objective on shares of RA Medical Systems in a report on Tuesday, March 26th. Cantor Fitzgerald reissued a “buy” rating and set a $11.00 price objective on shares of RA Medical Systems in a report on Tuesday, March 26th. Finally, Maxim Group decreased their price objective on shares of RA Medical Systems to $15.00 and set a “buy” rating for the company in a report on Friday, March 15th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $14.75.

RMED opened at $4.18 on Wednesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 11.64 and a quick ratio of 11.28. RA Medical Systems Inc has a twelve month low of $3.34 and a twelve month high of $22.00. The company has a market cap of $49.95 million and a PE ratio of -1.25.

RA Medical Systems (NYSE:RMED) last released its quarterly earnings data on Monday, May 13th. The company reported ($1.16) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.78). The firm had revenue of $1.75 million for the quarter, compared to analysts’ expectations of $1.22 million. As a group, research analysts predict that RA Medical Systems Inc will post -1.93 EPS for the current fiscal year.

WARNING: This piece of content was reported by Rockland Register and is owned by of Rockland Register. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://rocklandregister.com/2019/05/15/alethea-capital-management-llc-boosts-position-in-ra-medical-systems-inc-rmed.html.

RA Medical Systems Company Profile

Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.

See Also: How Investors Use a Balance Sheet

Want to see what other hedge funds are holding RMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RA Medical Systems Inc (NYSE:RMED).

Institutional Ownership by Quarter for RA Medical Systems (NYSE:RMED)

Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.